Bill of Health

DECEMBER 12, 2023

By Tara Davis and Nicola Soekoe In January 2021, the Director General of the World Health Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19 vaccines.

COVID-19 Vaccine 144

COVID-19 Vaccine COVID-19 Pharmaceutical Industry Public Health 144

Bill of Health

OCTOBER 26, 2023

However, the deep wounds of the pandemic remain, compelling those concerned about this pandemic and future health emergencies to account for catastrophic failures by those in power. Public health emergencies aren’t entirely preventable. Solidarity operates at two intersecting levels.

COVID-19 299

COVID-19 Public Health Pharmaceutical Industry World Health 299

Bill of Health

AUGUST 29, 2022

Like the Open COVID Pledge before it, Moderna’s pledge expressly states that it is valid only “ while the pandemic continues. government purchased millions of doses of Moderna’s mRNA vaccine, along with large quantities of vaccines manufactured by Pfizer. Pfizer made such a vaccine. From 2020 to 2022, the U.S.

COVID-19 Vaccine 362

COVID-19 Vaccine COVID-19 Licensing Governance 362

Bill of Health

SEPTEMBER 28, 2023

Despite having an outsized role in the discovery, development, manufacturing, and procurement of COVID-19 vaccines, therapeutics, and diagnostics, the federal government has generally not exercised any leverage in ensuring fair pricing and affordable access to these essential medical products. In 1989, the U.S.

COVID-19 205

COVID-19 COVID-19 Vaccine Pharmaceutical Industry Governance 205

Hall Render

FEBRUARY 18, 2022

CMS may now enforce its COVID-19 vaccination policy for healthcare workers in all 50 states. CMS responds to states seeking vaccination mandate waivers. Federal vaccination mandate begins for healthcare workers in 24 states. Lawmakers call on Biden to end public health emergency. The future St.

COVID-19 40

COVID-19 Nursing Homes Nurses COVID-19 Vaccine 40

Health Populi

FEBRUARY 22, 2021

The reputation of the pharmaceutical industry gained a “whopping” 30 points between January 2020 and February 2021, based on the latest Harris Poll in their research into industries’ reputations. The study was written up by Beth Snyder Bulik in FiercePharma. The coronavirus re-shaped people in the U.S.

COVID-19 154

COVID-19 COVID-19 Vaccine Pharmaceutical Industry Public Health 154